Mini Reviews : Insulin resistance and Alzheimer`s disease

참고문헌 (Reference)

1 De Ferrari, G. V., "Wnt signalingfunction in Alzheimer's disease" 33 : 1-12, 2000

2 Chen, G. J, "Transient hypoxia causesAlzheimer-type molecular and biochemical abnormalitiesin cortical neurons: potential strategies for neuroprotection" 5 : 209-228, 2003

3 Landreth, G., "Therapeutic use of agonists of the nuclearreceptor PPARgamma in Alzheimer's disease." 4 : 159-164, 2007

4 de la Monte, S. M, "Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevanceto Alzheimer's diseas" 10 : 89-109, 2006

5 D'Ercole, A. J., "The role of the insulin-like growth factorsin the central nervous system." 13 : 227-255, 1996

6 Lam, K, "The phosphatidylinositol 3-kinase serinekinase phosphorylates IRS-1. Stimulation by insulinand inhibition by Wortmannin" 269 : 20648-20652, 1994

7 Szkudelski, T., "The mechanism of alloxan andstreptozotocin action in B cells of the rat pancreas." 50 : 537-546, 2001

8 Nicolls, M. R., "The clinical and biological relationshipbetween Type II diabetes mellitus and Alzheimer'sdisease." 1 : 47-54, 2004

9 Wozniak, M, "The cellular and physiological actions of insulinin the central nervous system" 22 : 1-10, 1993

10 Hoyer, S., "The aging brain. Changes in the neuronalinsulin/insulin receptor signal transduction cascade triggerlate-onset sporadic Alzheimer disease (SAD)." 109 : 991-1002, 2002

11 Shpakov, A. O., "Structural andfunctional characterization of insulin receptor substrateproteins and the molecular mechanisms of their interactionwith insulin superfamily tyrosine kinase receptorsand effector proteins." 13 : 455-484, 2000

12 Holland, W. L, "Sphingolipids,insulin resistance, and metabolic disease: new insightsfrom in vivo manipulation of sphingolipid metabolism" 29 : 381-402, 2008

13 de la Monte, S. M, "Review of insulinand insulin-like growth factor expression, signaling,and malfunction in the central nervous system: relevanceto Alzheimer's disease" 7 : 45-61, 2005

14 Dudek, H, "Regulation of neuronal survivalby the serine-threonine protein kinase Akt [see comments]" 275 : 661-665, 1997

15 Cook, D. G., "Reduced hippocampalinsulin-degrading enzyme in late-onset Alzheimer's diseaseis associated with the apolipoprotein E-epsilon4allele" 162 : 313-319, 2003

16 Pete, G., "Postnatal growth responses to insulin-like growth factor Iin insulin receptor substrate-1-deficient mice" 140 : 5478-5487, 1999

17 Sun, X. J, "Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1" 13 : 7418-7428, 1993

18 Tong, M., "Nitrosamine-mediatedtype 2 diabetes mellitus, hepatic steatosis, and alzheimer-type neurodegeneration: potential role of environmentalexposures in our insulin resistance diseasespandemic" 2009

19 Halestrap, A. P, "Mitochondria and cell death." 28 : 170-177, 2000

20 Winocur, G, "Memory impairment in obese Zucker rats: an investigationof cognitive function in an animal model of insulinresistance and obesity" 119 : 1389-1395, 2005

21 Reger, M. A, "Intranasal insulin improves cognition and modulates{beta}-amyloid in early AD." 70 : 440-448, 2008

22 Duelli, R., "Intracerebroventricular injection of streptozotocininduces discrete local changes in cerebral glucose utilizationin rats." 12 : 737-743, 1994

23 Lester-Coll, N, "Intracerebralstreptozotocin model of type 3 diabetes: relevance tosporadic Alzheimer's disease" 9 : 13-33, 2006

24 Arboleda, G, "Insulin-likegrowth factor-1-dependent maintenance of neuronal metabolismthrough the phosphatidylinositol 3-kinase-Aktpathway is inhibited by C2-ceramide in CAD cells" 25 : 3030-3038, 2007

25 Dore, S, "Insulin-likegrowth factor I protects and rescues hippocampal neuronsagainst beta-amyloid- and human amylin-induced toxicity" 94 : 4772-4777, 1997

26 Zheng, W. H, "Insulin-like growth factor-1 (IGF-1): a neuroprotective trophicfactor acting via the Akt kinase pathway" 60 : 261-272, 2000

27 Bernstein, H. G, "Insulin-degrading enzymein the Alzheimer's disease brain: prominent localizationin neurons and senile plaques" 263 : 161-164, 1999

28 Capeau, J., "Insulin resistance and steatosis inhumans." 34 : 649-957, 2008

29 Craft,S, "Insulin resistance and Alzheimer's diseasepathogenesis: potential mechanisms and implications fortreatment" 4 : 147-152, 2007

30 Schubert, M., "Insulin receptorsubstrate-2 deficiency impairs brain growth andpromotes tau phosphorylation." 23 : 7084-7092, 2003

31 Giovannone, B, "Insulin receptor substrate (IRS)transduction system: distinct and overlapping signalingpotential" 16 : 434-441, 2000

32 Hong, M, "Insulin and insulin-likegrowth factor-1 regulate tau phosphorylation in culturedhuman neurons." 272 : 19547-19553, 1997

33 Rivera, E. J, "Insulin and insulin-likegrowth factor expression and function deteriorate withprogression of Alzheimer's disease: link to brain reductionsin acetylcholine" 8 : 247-268, 2005

34 Hoyer, S, "Inhibition of the neuronal insulin receptor. An in vivomodel for sporadic Alzheimer disease?" 920 : 256-258, 2000

35 Steen, E, "Impaired insulin and insulin-like growth factorexpression and signaling mechanisms in Alzheimer'sdisease--is this type 3 diabetes?" 7 : 63-80, 2005

36 Ullrich, A., "Human insulin receptor and its relationshipto the tyrosine kinase family of oncogenes" 313756761 : 1985

37 Lyn-Cook, L. E., "Hepatic ceramide mediates braininsulin resistance and neurodegeneration in obesity withtype 2 diabetes mellitus and Non-alcoholoic steatohepatitis" 16 : 715-729, 2008

38 Hoyer, S, "Glucose metabolism and insulin receptorsignal transduction in Alzheimer disease." 490 : 115-125, 2004

39 Doble, B. W., "GSK-3: tricks ofthe trade for a multi-tasking kinase" 116 : 1175-1186, 2003

40 de la Monte, S. M., "Epidemilogical trends strongly suggest exposuresas etiologic agents in the pathogenesis of sporadicAlzheimer's disease, diabetes mellitus, and non- alcoholicsteatohepatitis" 17 : 519-529, 2009

41 Gasparini, L., "Does insulin dysfunction play a role in Alzheimer'sdisease?" 23 : 288-289, 2002

42 Pasquier, F, "Diabetes mellitus and dementia." 32 : 403-414, 2006

43 Elwing, J. E., "Depression, anxiety, and nonalcoholic steatohepatitis" 68 : 563-569, 2006

44 McDermott, J. R, "Degradationof Alzheimer's beta-amyloid protein by human and ratbrain peptidases: involvement of insulin-degrading enzyme" 22 : 49-56, 1997

45 Ait-Ghezala, G, "Confirmation of association betweenD10S583 and Alzheimer's disease in a case--controlsample." 325 : 87-90, 2002

46 Perry, W, "Cognitive dysfunction in chronic hepatitis C: a review" 53 : 307-321, 2008

47 Mandelkow, E. M, "Clogging of axons by tau, inhibitionof axonal traffic and starvation of synapses" 24 : 1079-1085, 2003

48 Hoyer, S, "Cerebral excess release ofneurotransmitter amino acids subsequent to reduced cerebralglucose metabolism in early-onset dementia ofAlzheimer type." 75 : 227-232, 1989

49 Summers, S. A., "Ceramides in insulin resistance andlipotoxicity." 45 : 42-72, 2006

50 Tong, M., "Ceramide- mediatedneurodegeneration: relevance to Diabetes-associatedneurodegeneration." 16 : 705-714, 2009

51 Hajduch, E., "Ceramide impairs the insulin-dependent membrane recruitmentof protein kinase B leading to a loss in downstreamsignalling in L6 skeletal muscle cells" 44 : 173-183, 2001

52 Condorelli, F, "Caspase cleavage enhances the apoptosis-inducing effectsof BAD." 21 : 3025-3036, 2001

53 Hoyer,S, "Brain glucose and energy metabolism abnormalitiesin sporadic Alzheimer disease. Causes andconsequences: an update" 35 : 1363-1372, 2000

54 Martins, I. J., "Apolipoprotein E, cholesterol metabolism,diabetes, and the convergence of risk factors forAlzheimer's disease and cardiovascular disease." 11 : 721-736, 2006

55 Balasubramanian, A. S., "Amyloid beta peptide processing,insulin degrading enzyme, and butyrylcholinesterase." 26 : 453-456, 2001

56 de la Monte, S. M, "Alzheimer'sdisease is type 3 diabetes: evidence reviewed" 2 : 1101-1113, 2008

57 Lovestone, S., "Alzheimer's disease-like phosphorylation of themicrotubule-associated protein tau by glycogen synthasekinase-3 in transfected mammalian cells." 4 : 1077-1086, 1994

58 Xie, L, "Alzheimer's beta-amyloid peptides compete for insulin binding to the insulinreceptor." 22 : 221-, 2002